Wellbutrin Related Published Studies
Well-designed clinical trials related to Wellbutrin (Bupropion)
Psychological mediators of bupropion sustained-release treatment for smoking cessation. [2008.09]
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. [2008.08.01]
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. [2008.08]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2008.07.17]
Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. [2008.07]
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. [2008.06.01]
A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. [2008.06]
Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion. [2008.04.02]
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. [2008.04]
Bupropion for the treatment of methamphetamine dependence. [2008.04]
Bupropion improves attention but does not affect impulsive behavior in healthy young adults. [2008.04]
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. [2008.03]
Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. [2008.01]
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder. [2008]
Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. [2008]
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials. [2007.12]
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial. [2007.12]
Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. [2007.11]
A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care. [2007.09.10]
Bupropion SR for the treatment of smokeless tobacco use. [2007.09.06]
Efficacy of bupropion alone and in combination with nicotine gum. [2007.09]
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. [2007.08]
A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. [2007.08]
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. [2007.08]
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. [2007.08]
Bupropion and nicotine patch as smoking cessation aids in alcoholics. [2007.08]
Bupropion and cognitive-behavioral treatment for depression in smoking cessation. [2007.07]
A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. [2007.07]
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. [2007.06.26]
Bupropion and cognitive-behavioral therapy for smoking cessation in women. [2007.06]
Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. [2007.05]
Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR. [2007.05]
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. [2007.04]
A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. [2007.04]
Bupropion SR for the treatment of smokeless tobacco use. [2007.03.10]
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. [2007.02]
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. [2007.01.01]
Bupropion in the treatment of outpatients with asthma and major depressive disorder. [2007]
Bupropion for smokers hospitalized with acute cardiovascular disease. [2006.12]
No evidence for a major role of polymorphisms during bupropion treatment. [2006.11]
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. [2006.08.14]
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. [2006.07.05]
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. [2006.07.05]
Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. [2006.07]
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. [2006.05]
Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers. [2006.05]
Extended treatment with bupropion SR for cigarette smoking cessation. [2006.04]
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. [2006.03.23]
Sexual function during bupropion or paroxetine treatment of major depressive disorder. [2006.03]
An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. [2006.03]
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. [2006.02]
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. [2006.02]
Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials. [2006.01]
A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. [2006]
The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. [2005.12]
Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. [2005.11]
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. [2005.10.24]
Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. [2005.10]
A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. [2005.10]
A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation. [2005.10]
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. [2005.09]
An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. [2005.07.25]
A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. [2005.07]
Inhibition of CYP2D6 activity by bupropion. [2005.06]
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. [2005.06]
Exposure measures applied to the bioequivalence of two sustained release formulations of bupropion. [2005.05]
Bupropion SR vs placebo for smoking cessation in health care professionals. [2005.05]
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. [2005.04.01]
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. [2005.04]
Effect of bupropion on nocturnal urinary free cortisol and its association with antidepressant response. [2005.03]
Efficacy of bupropion in the indigenous Maori population in New Zealand. [2005.02]
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. [2005]
Effect of bupropion on depression symptoms in a smoking cessation clinical trial. [2004.12]
Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results. [2004.11]
Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial. [2004.11]
Bupropion for smoking cessation: a randomized trial. [2004.09.13]
Bupropion SR for relapse prevention: a "slips-allowed" analysis. [2004.09]
Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective. [2004.09]
Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. [2004.09]
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. [2004.08]
Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. [2004.08]
Suitability of bupropion SR for nicotine-dependent smokers: problems in a practice setting. [2004.07]
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. [2004.06]
Do small lapses predict relapse to smoking behavior under bupropion treatment? [2004.04]
Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. [2004.04]
Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. [2004.04]
Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine. [2004.03]
Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective. [2004.03]
Assessing the effects of bupropion SR on mood dimensions of depression. [2004.03]
Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. [2004.02.01]
A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. [2004.02]
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. [2004.02]
A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. [2004.01]
Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement. [2004.01]
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? [2003.12]
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. [2003.12]
Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. [2003.10.27]
Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation. [2003.10]
Does menthol attenuate the effect of bupropion among African American smokers? [2003.10]
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. [2003.08]
Neurochemical and psychotropic effects of bupropion in healthy male subjects. [2003.06]
|
